Literature DB >> 11569698

Prevalence of celiac disease in Argentina: screening of an adult population in the La Plata area.

J C Gomez1, G S Selvaggio, M Viola, B Pizarro, G la Motta, S de Barrio, R Castelletto, R Echeverría, E Sugai, H Vazquez, E Mauriño, J C Bai.   

Abstract

OBJECTIVES: Up to now, the epidemiological characteristic of celiac disease among adults in South America remains unknown. The present prospective screening was designed to determine the prevalence of celiac disease in adults from the general population in an urban area of Argentina.
METHODS: Between January. 1998, and May, 2000, all couples attending a centralized laboratory for an obligatory prenuptial examination in the La Plata area were offered participation in a screening program for celiac disease. The study included 2000 subjects (996 women; median age 29 yr, range 16-79 yr). All individuals completed a clinical questionnaire at the time that serum samples were obtained. A three-step screening protocol was used, as follows: 1) all samples were tested for antigliadin antibodies (AGAs) (type IgA and IgG); 2) samples that were IgA AGA positive were tested for antiendomysial antibody (EmA type IgA); samples that were positive for AGA-G but negative for IgA AGAs were tested for total IgA serum levels and EmA type IgG; and 3) subjects who were EmA-positive were referred for intestinal biopsy.
RESULTS: At the end of the screening we detected 10 subjects who were EmA-A positive and two others who were IgA-deficient (both were EmA-G positive). Up to now, 11 of the 12 subjects (including nine EmA-positive and two IgA-deficient subjects) had endoscopic intestinal biopsies showing the characteristic celiac histology. The remaining EmA-positive individual was considered to be affected by celiac disease. The overall prevalence assessed was 1:167 (6.0 x 1000 subjects; 95% CI = 3.1-10.5). Eight of the 12 (67%) subjects were female (1:124; 8.0 x 1000; 95% CI = 3.5-15.8) and four (33%) were male (1:251; 4.0 x 1000; 95% Cl = 1.1-10.2). Although eight new patients were considered to be asymptomatic, three presented with a subclinical course and one was classically symptomatic. Only one patient had been previously diagnosed with celiac disease.
CONCLUSIONS: Our screening protocol showed a very high prevalence of celiac disease for an urban area of Argentina that is ethnically similar to 90% of the general population of the country. The prevalence among women was double that for men, and the heterogeneous clinical picture of new patients showed predominance of asymptomatic cases.

Entities:  

Mesh:

Year:  2001        PMID: 11569698     DOI: 10.1111/j.1572-0241.2001.04124.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  34 in total

1.  Increasing incidence of enteropathy-associated T-cell lymphoma in the United States, 1973-2008.

Authors:  Reem Z Sharaiha; Ben Lebwohl; Laura Reimers; Govind Bhagat; Peter H Green; Alfred I Neugut
Journal:  Cancer       Date:  2011-12-13       Impact factor: 6.860

2.  Seroprevalence, correlates, and characteristics of undetected coeliac disease in England.

Authors:  J West; R F A Logan; P G Hill; A Lloyd; S Lewis; R Hubbard; R Reader; G K T Holmes; K-T Khaw
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

3.  Celiac disease and the forgotten 10%: the "silent minority".

Authors:  Benjamin Lebwohl
Journal:  Dig Dis Sci       Date:  2015-06       Impact factor: 3.199

Review 4.  Recent advances in coeliac disease.

Authors:  D A van Heel; J West
Journal:  Gut       Date:  2006-07       Impact factor: 23.059

Review 5.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

6.  The prevalence of celiac disease in blood donors in Iceland.

Authors:  Gudmundur F Johannsson; Gudjon Kristjansson; Nick Cariglia; Vigfus Thorsteinsson
Journal:  Dig Dis Sci       Date:  2008-07-04       Impact factor: 3.199

Review 7.  Screening for celiac disease in the general population and in high-risk groups.

Authors:  Jonas F Ludvigsson; Timothy R Card; Katri Kaukinen; Julio Bai; Fabiana Zingone; David S Sanders; Joseph A Murray
Journal:  United European Gastroenterol J       Date:  2015-04       Impact factor: 4.623

Review 8.  Celiac disease: prevalence, diagnosis, pathogenesis and treatment.

Authors:  Naiyana Gujral; Hugh J Freeman; Alan B R Thomson
Journal:  World J Gastroenterol       Date:  2012-11-14       Impact factor: 5.742

9.  Seroprevalence of celiac disease among healthy adolescents in Saudi Arabia.

Authors:  Abdulrahman M Aljebreen; Majid A Almadi; Alwaleed Alhammad; Faleh Z Al Faleh
Journal:  World J Gastroenterol       Date:  2013-04-21       Impact factor: 5.742

10.  Prevalence of celiac disease in an urban area of Brazil with predominantly European ancestry.

Authors:  Maria Angélica G Pereira; Carmen L Ortiz-Agostinho; Iêda Nishitokukado; Maria-N Sato; Adérson O M C Damião; Marília L Alencar; Clarice P Abrantes-Lemos; Eduardo L R Cançado; Thales de Brito; Sérgio O Ioshii; Sandra B M Valarini; Aytan M Sipahi
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.